Nasal mask
Facial mask
Nasal prongs
Mouthpiece
Age
Every age
Every age
Adolescent
Child and adolescent
Contraindications
Gastroesophageal reflux, patient without autonomy
Advantages
Small volume, comfortable, allows eating and speaking, allows the use of a pacifier in infants
No mouth leaks
No facial contact
Use at libitum (neuromuscular patients)
Limitations
Mouth leaks
Large volume (risk of rebreathing)
Mouth leaks
Ability to seal lips around the mouthpiece (leaks)
Air leaks are the main limitation of NPPV, especially with nasal masks. Leaks are the main cause of persistent hypercapnia (Gonzalez et al. 2003; Paiva et al. 2009). Simple practical measures, such as changing the mask, using a chin strap, increasing minute ventilation and changing the type of the ventilator, may be able to reduce the volume of air leaks and improve the efficacy of ventilation (Gonzalez et al. 2003; Paiva et al. 2009).
Skin erythema or irritation is also a major side effect of the interface (Fauroux et al. 2005). This complication has to be detected and prevented as early as possible by changing the interface or making a custom-made mask. The pressure applied by the interface on the growing facial structures of a child can induce facial deformities. A systematic maxillofacial evaluation before, during and after the eventual withdrawal of NPPV is mandatory. The interface needs also to be changed frequently in young children, because of their rapid facial growth. It may be recommended to use and alternate different (types of) masks to minimise the risk of skin injury and facial deformity. Systematic humidification of the ventilator gas is not necessary for NPPV because of the respect of the upper airway. However, nasal intolerance due to excessive dryness can resolve after humidification of the ventilator gas. Most importantly, the evaluation of the efficacy of NPPV should consider the “couple” interface + ventilator because the change of the interface or the ventilator may modify the effectiveness of NPPV (Louis et al. 2010b).
10.4 Practical Organisation and Backup Systems
The major advantage of NPPV is that it can be applied at home, combining greater potential for psychosocial development and family function, at lesser cost. The use of home NPPV requires appropriate diagnostic procedures, appropriate titration of the ventilator, cooperative and educated families and a careful, well-organised follow-up. Prior to discharge, the patient’s respiratory status should be stable on the actual ventilator and circuit the child will use at home, at least for several days. Settings on a home ventilator do not provide the same ventilation in the child as the same settings on a hospital ventilator, and the efficacy of home equipment must be evaluated in each child prior to discharge. Once the child is at home, and as the child grows, ventilator settings must be evaluated to ensure adequate gas exchange on a regular basis. Although the optimal frequency for these evaluations has not been determined, these evaluations should be performed more frequently in infants and small children because of their rapid growth. Sleep evaluations are recommended as a diagnostic tool before the initiating of NPPV, then as a control test of the efficacy of NPPV before discharge with the ventilator, and as a surveillance test during an overnight hospital admission during follow-up (Paiva et al. 2009). Careful extrapolation should be made from a sleep evaluation performed during daytime naps because this does not always reflect what happens during the night. Routine and emergency service must be available. Providers/home care equipment technicians and nurses should visit the patient at home at least every month to perform preventive maintenance and check of the interface and the ventilator. Evaluation of compliance should be systematically checked by counters on the equipment determining the amount of time the ventilator is effectively used and not only turned on.
Patients requiring home NPPV may need other supportive therapies. Cough-assisted techniques, by means of the mechanical insufflator-exsufflator, for example, are recommended in every patient with neuromuscular disease who is started on NPPV. The mechanical insufflator-exsufflator is very efficient and well-tolerated in helping the patient clear his respiratory secretions (Fauroux et al. 2008b). Oxygen therapy at home must be justified on the basis of an individual-based medical necessity, as determined by appropriate physiological monitoring, with pulse oximetry monitoring during periods of sleep, wakefulness, feeding and physical activity and arterial blood gases. CO2 levels should be minimised first by ventilator use before considering oxygen therapy, especially for patients with neuromuscular disorders and obstructive sleep apnoea. It is important to remember that supplemental oxygen is not a replacement for assisted ventilation in patients who hypoventilate.